Lexaria Cash from 2010 to 2024
| LEXX Stock | USD 2.08 0.01 0.48% |
Cash | First Reported 2005-11-30 | Previous Quarter 8.5 M | Current Value 6.5 M | Quarterly Volatility 2.7 M |
Check Lexaria Bioscience financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Lexaria Bioscience's main balance sheet or income statement drivers, such as Depreciation And Amortization of 132.7 K, Interest Expense of 107.8 K or Other Operating Expenses of 3.2 M, as well as many indicators such as Price To Sales Ratio of 105, Dividend Yield of 0.0 or PTB Ratio of 54.87. Lexaria financial statements analysis is a perfect complement when working with Lexaria Bioscience Valuation or Volatility modules.
Lexaria | Cash |
Latest Lexaria Bioscience's Cash Growth Pattern
Below is the plot of the Cash of Lexaria Bioscience Corp over the last few years. Cash refers to the most liquid asset of Lexaria Bioscience Corp, which is listed under current asset account on Lexaria Bioscience Corp balance sheet and usually includes currency, coins, checking accounts, and not deposited checks received from Lexaria Bioscience customers. The amounts must be unrestricted with restricted cash listed in a different Lexaria Bioscience account. It is the total amount of money in the form of currency that a company has in its possession. This includes all bills, coins, and funds in bank accounts. Lexaria Bioscience's Cash historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Lexaria Bioscience's overall financial position and show how it may be relating to other accounts over time.
| Cash | 10 Years Trend |
|
Cash |
| Timeline |
Lexaria Cash Regression Statistics
| Arithmetic Mean | 2,664,698 | |
| Geometric Mean | 1,039,490 | |
| Coefficient Of Variation | 123.16 | |
| Mean Deviation | 2,586,265 | |
| Median | 1,293,749 | |
| Standard Deviation | 3,281,889 | |
| Sample Variance | 10.8T | |
| Range | 10.9M | |
| R-Value | 0.69 | |
| Mean Square Error | 6.1T | |
| R-Squared | 0.47 | |
| Significance | 0 | |
| Slope | 505,059 | |
| Total Sum of Squares | 150.8T |
Lexaria Cash History
Other Fundumenentals of Lexaria Bioscience Corp
| Cash And Short Term Investments | ||
| Change In Cash | ||
| Free Cash Flow | ||
| Other Cashflows From Financing Activities |
Lexaria Bioscience Cash component correlations
Click cells to compare fundamentals
About Lexaria Bioscience Financial Statements
Lexaria Bioscience investors use historical fundamental indicators, such as Lexaria Bioscience's Cash, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Lexaria Bioscience. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Cash | 6.5 M | 6.8 M | |
| Cash And Short Term Investments | 6.6 M | 6.9 M | |
| Change In Cash | 5.1 M | 5.4 M | |
| Free Cash Flow | -5 M | -4.7 M | |
| Other Cashflows From Financing Activities | 6.1 M | 6.4 M | |
| Total Cash From Operating Activities | -5 M | -4.7 M | |
| Total Cash From Financing Activities | 10.3 M | 10.8 M | |
| End Period Cash Flow | 6.5 M | 6.8 M | |
| Begin Period Cash Flow | 1.4 M | 1.8 M | |
| Other Non Cash Items | 174.7 K | 166 K | |
| Total Cashflows From Investing Activities | -207.7 K | -218.1 K | |
| Operating Cash Flow Per Share | (0.40) | 0.01 | |
| Free Cash Flow Per Share | (0.40) | 0.01 | |
| Capex To Operating Cash Flow | 0.29 | 0.30 | |
| EV To Operating Cash Flow | (8.48) | 362.55 | |
| EV To Free Cash Flow | (8.48) | 507.35 | |
| Price To Operating Cash Flows Ratio | (9.76) | 358.78 | |
| Price To Free Cash Flows Ratio | (9.76) | 502.06 | |
| Cash Ratio | 5.91 | 0.05 | |
| Cash Conversion Cycle | -80 K | -16.59 | |
| Operating Cash Flow Sales Ratio | (10.68) | 0.29 | |
| Free Cash Flow Operating Cash Flow Ratio | 0.71 | 0.68 | |
| Cash Flow Coverage Ratios | (36.10) | 0.25 | |
| Price Cash Flow Ratio | (9.76) | 358.78 | |
| Cash Flow To Debt Ratio | (36.10) | 0.25 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Lexaria Stock Analysis
When running Lexaria Bioscience's price analysis, check to measure Lexaria Bioscience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lexaria Bioscience is operating at the current time. Most of Lexaria Bioscience's value examination focuses on studying past and present price action to predict the probability of Lexaria Bioscience's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lexaria Bioscience's price. Additionally, you may evaluate how the addition of Lexaria Bioscience to your portfolios can decrease your overall portfolio volatility.